Abstract
Since the rise of evidence-based medicine movement, systematic reviews and meta-analyses have been widely used for synthesis of evidence on beneficial and/or harmful effects of different treatments. Moreover, with the advances in medical science and knowledge, many new treatments and interventions become available, and identifying how best to compare multiple treatments is an important challenge to evidence-based medicine. Although network meta-analysis is a very powerful tool for comparing multiple treatments in terms of their benefits or harms, it requires a lot of resources and a substantial amount of time for literature search, data extraction and statistical analysis. If a decision based on currently available evidence needs to be made urgently, it might not be feasible to undertake network meta-analysis within a short period of time. Nevertheless, many traditional pairwise meta-analyses of a good quality may have been published, and there are great overlaps in literature search and data extractions between those pairwise meta-analyses and a network meta-analysis. If results of traditional meta-analysis can be used for an expedient comparison of multiple treatments, this would help researchers spend less time and resources in reaching a decision within a shorter period of time. Statistical models for an umbrella review are similar to those for a network meta-analysis, as they both aim to compare multiple treatments. Both Bayesian approach and generalized least-squares approach can be used to conduct statistical analysis for an umbrella review. This will be especially useful for policy makers or busy clinicians to obtain up-to-date evidence to make an informed decision.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hasselblad V. Meta-analysis of multitreatment studies. Med Decis Making. 1998;18(1):37–43.
Bucher HC, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683–91.
Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002;21(16):2313–24.
Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105–24.
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373:746–58.
Cipriani A, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378(9799):1306–15.
Tu YK, Woolston A, Faggion Jr CM. Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials. J Clin Periodontol. 2010;37(1):59–79.
Wong MC, et al. Cochrane reviews on the benefits/risks of fluoride toothpastes. J Dent Res. 2011;90(5):573–9.
Tu Y-K, et al. A bayesian network meta-analysis on comparisons of enamel matrix derivatives, guided tissue regeneration and their combination therapies. J Clin Periodontol. 2012;39(3):303–14.
Dias S, et al. Evidence synthesis for decision making 1: introduction. Med Decis Making. 2013;33(5):597–606.
Dias S, et al. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33(5):607–17.
Dias S, et al. Evidence synthesis for decision making 3: heterogeneity – subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making. 2013;33(5):618–40.
Dias S, et al. Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making. 2013;33(5):641–56.
Dias S, et al. Evidence synthesis for decision making 5: the baseline natural history model. Med Decis Making. 2013;33(5):657–70.
Dias S, et al. Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis. Med Decis Making. 2013;33(5):671–8.
Ades AE, et al. Evidence synthesis for decision making 7: a reviewer’s checklist. Med Decis Making. 2013;33(5):679–91.
Andrea Cipriani JPTH, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159:130–7.
Moe RH, et al. Effectiveness of nonpharmacological and nonsurgical interventions for hip osteoarthritis: an umbrella review of high-quality systematic reviews. Phys Ther. 2007;87(12):1716–27.
Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009;181(8):488–93.
Caldwell DM, Welton NJ, Ades AE. Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. J Clin Epidemiol. 2010;63(8):875–82.
Tu Y-K. Use of generalized linear mixed models for network meta-analysis. Med Decis Making. 2014;34(7):911–8.
Tu Y-K. Linear mixed model approach to network meta-analysis for continuous outcomes in periodontal research. J Clin Periodontol. 2015;42(2):204–12.
Rabe-Hesketh S, Skrondal A, Pickles A. Generalized multilevel structural equation modelling. Psychometrika. 2004;69(2):167–90.
Rabe-Hesketh S, Skrondal A, Pickles A. Maximum likelihood estimation of limited and discrete dependent variable models with nested random effects. J Econom. 2005;128(2):301–23.
Macfadyen CA, Acuin JM, Gamble CL. Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations (review). Cochrane Database Syst Rev. 2005;(4):CD004618.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Appendix 10.1: WinBUGS Code of Umbrella Review
#MODEL
model{
for (i in 1:N){
LOR[i]~dnorm(lor[comp[i],treat[i]],prec[i])
prec[i]<-1/var[i]
var[i]<-sd[i]*sd[i]
sd[i]<-(LUCI[i]-LLCI[i])/3.92
dev[i]<-(LOR[i]-lor[comp[i],treat[i]])*(LOR[i]-lor[comp[i],treat[i]])*prec[i]
}
resdev<-sum(dev[]) #summed residual deviance
d[1]<-0
for (k in 2:NT){
d[k]~dnorm(0,0.0001) #vague prior for basic parameters
}
for (k in 1:NT){
best[k]<-equals(rank(d[],k),1)
}
for (c in 1:NT-1){
for (k in (c+1):NT){
lor[c,k]<-d[k]-d[c]
or[c,k]<-exp(lor[c,k])
}
}
}
#DATA for FE
list(N=4, NT=4,
comp=c(1,2,2,3),
treat=c(2,3,4,4),
LOR=c(-1.993,0.279,1.14,0.83),
LLCI=c(-2.583,0.038,0.868,0.359),
LUCI=c(-1.402,0.521,1.412,1.3)
)
#DATA for RE
list(N=4, NT=4,
comp=c(1,2,2,3),
treat=c(2,3,4,4),
LOR=c(-2.528,0.412,1.453,1.011),
LLCI=c(-4.345,-0.166,0.58,-0.839),
LUCI=c(-0.711,0.991,2.327,2.86)
)
#INITIAL VALUES
list(
d=c(NA, 0,0,0)
)
Appendix 10.2: Stata Codes for Statistical Analysis of Umbrella Reviews
Using weighted least squares (WLS) method
vwls d t12-t14, noconstant sd(se)
Using Stata command GLLAMM
generate lns = ln(se)
* set up lns as the lower level residual variance
eq het: lns
* set constraint 1: the coefficient for lns is 1
constraint define 1 [lns1]lns=1
* generate a new variable cons which is a vector of 1
gene cons=1
* set up random intercept model for treatment effect
eq int: cons
* constrain the variance of random effects to 0, so it becomes a fixed effect analysis
constraint define 2 [stud1]_cons=0
* run the fixed effect analysis using gllamm
gllamm d t12-t14, noconstant i(study) constraint(1 2) adapt s(het) nip(5)
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chen, TT., Tu, YK. (2016). Statistical Models for Overviews of Reviews. In: Biondi-Zoccai, G. (eds) Umbrella Reviews. Springer, Cham. https://doi.org/10.1007/978-3-319-25655-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-25655-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-25653-5
Online ISBN: 978-3-319-25655-9
eBook Packages: MedicineMedicine (R0)